FC
GMAB icon

Financial Consulate’s Genmab GMAB Stock Holding History

Financial Consulate’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.25K Buy
270
+60
+29% +$1.8K ﹤0.01% 716
2025
Q4 		$6.47K Buy
210
+20
+11% +$623 ﹤0.01% 693
2025
Q3 		$5.83K Buy
+190
New +$4.63K ﹤0.01% 629

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Financial Consulate's GMAB Position: Q1 2026 in Review

Financial Consulate increased its Genmab (GMAB) stake by 29% in Q1 2026, buying an estimated $1.8K and bringing the position to 270 shares worth $7.25K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

Financial Consulate first reported a position in GMAB in Q3 2025 and has held it in 3 quarters since. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Financial Consulate held 270 shares of Genmab worth $7.25K as of Q1 2026.
  • Financial Consulate bought 60 Genmab shares in Q1 2026, an estimated $1.8K.
  • Genmab made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #716 holding.
  • Financial Consulate first reported a position in Genmab in Q3 2025 and has held it in 3 quarters since.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.